LEDBURY HEALTH PARTNERSHIP — All Prescriptions & Medications
Practice Code: M81012 | LEDBURY, HR8 2AQ
Over the last 12 months, LEDBURY HEALTH PARTNERSHIP prescribed 265,402 items across 658 different medications at a total cost of £2,419,830 to the NHS. Below is the complete list of all medications prescribed, sorted by volume.
| Medication | Items (12m) ↑ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Metolazone | 10 | 40 | £262 | +41.7% ▲ |
| Irbesartan with diuretic | 10 | 280 | £113 | -36.4% ▼ |
| Ciclesonide | 10 | 10 | £261 | -32.1% ▼ |
| Potassium chloride | 10 | 280 | £27 | -46.5% ▼ |
| Other health supplement preparations | 10 | 300 | £44 | -78.9% ▼ |
| 10 | 100 | £127 | -8.7% ▼ | |
| 10 | 117 | £28 | -72.0% ▼ | |
| 10 | 27 | £458 | -27.6% ▼ | |
| 10 | 600 | £1.9K | +7.1% ▲ | |
| 10 | 450 | £1.7K | -18.5% ▼ | |
| 10 | 360 | £2.3K | +43.2% ▲ | |
| Zinc oxide | 11 | 449 | £52 | -46.8% ▼ |
| Metoprolol tartrate | 11 | 1,260 | £367 | -78.3% ▼ |
| Lormetazepam | 11 | 660 | £217 | -6.6% ▼ |
| Ketoprofen | 11 | 800 | £35 | -69.3% ▼ |
| Phenazone/lidocaine | 11 | 165 | £93 | +7.6% ▲ |
| Co-cyprindiol (Cyprote acetate/ethinylestradiol) | 11 | 693 | £94 | +26.8% ▲ |
| Chlorhexidine gluconate | 11 | 5,000 | £85 | -62.8% ▼ |
| Lidocaine | 11 | 225 | £168 | -4.3% ▼ |
| 11 | 85 | £232 | -33.9% ▼ | |
| 11 | 22 | £2.2K | +26.3% ▲ | |
| 11 | 75 | £2.4K | +98.8% ▲ | |
| 11 | 2,100 | £311 | -38.1% ▼ | |
| 11 | 308 | £58 | -60.0% ▼ | |
| 11 | 660 | £1.1K | +4.7% ▲ | |
| Terazosin hydrochloride | 12 | 336 | £24 | -26.2% ▼ |
| Naftidrofuryl oxalate | 12 | 3,864 | £472 | -63.2% ▼ |
| Ketotifen fumarate | 12 | 840 | £194 | +37.9% ▲ |
| Lofepramine hydrochloride | 12 | 486 | £280 | -59.9% ▼ |
| Levonorgestrel | 12 | 12 | £973 | -68.2% ▼ |
| Solifenacin/tamsulosin | 12 | 360 | £315 | -41.6% ▼ |
| Sodium feredetate | 12 | 6,000 | £171 | -58.1% ▼ |
| Budesonide | 12 | 12 | £120 | -22.8% ▼ |
| Clindamycin/tretinoin | 12 | 390 | £148 | +2.2% ▲ |
| Other individually formulated bought in preparations | 12 | 566 | £991 | -63.3% ▼ |
| 12 | 136 | £147 | -62.9% ▼ | |
| 12 | 154 | £718 | +150.0% ▲ | |
| 12 | 12 | £339 | +39.7% ▲ | |
| 12 | 42 | £268 | -5.7% ▼ | |
| 12 | 24 | £1.2K | +31.7% ▲ | |
| 12 | 120 | £373 | -41.1% ▼ | |
| 12 | 85 | £136 | -27.3% ▼ | |
| 12 | 390 | £1.2K | +8.8% ▲ | |
| 12 | 720 | £1.8K | +16.6% ▲ | |
| 12 | 360 | £788 | +34.9% ▲ | |
| Captopril | 13 | 4,856 | £4.5K | -10.2% ▼ |
| Alimemazine tartrate | 13 | 5,850 | £5.4K | +0.5% vs avg |
| Lurasidone | 13 | 364 | £988 | -47.9% ▼ |
| Imipramine hydrochloride | 13 | 728 | £29 | -49.0% ▼ |
| Doxylamine succinate/pyridoxine hydrochloride | 13 | 700 | £998 | +17.8% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.